Poisoning by Synthetic Cannabis Research Dashboard
Double-blind human trials
Clinical human trials
What am I missing as a non-subscriber?
To see a full dashboard with study details and filtering, go to our DEMO page.
As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.
CannaKeys has 63 studies associated with Poisoning by Synthetic Cannabis.
Here is a small sampling of Poisoning by Synthetic Cannabis studies by title:
- Effects of synthetic (JWH-018) cannabinoids treatment on spermatogenesis and sperm function
- Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
- Abuse Potential of Synthetic Cannabinoids: AM-1248, CB-13, and PB-22
- Catatonia Related to Cannabis and Synthetic Cannabinoids: A Review
- Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre
Components of the Poisoning by Synthetic Cannabis Research Dashboard
- Dosing information available for Poisoning by Synthetic Cannabis
- Chemotype guidance for treating Poisoning by Synthetic Cannabis with cannabis
- Synopsis of cannabis research for Poisoning by Synthetic Cannabis
- Individual study details for Poisoning by Synthetic Cannabis
Ready to become a subscriber? Go to our PRICING page.
Members can filter by the following criteria:
- Study Type
- Cannabinoids & Endocannabinoids
- Study Result
- Year of Publication
Overview - Poisoning by Synthetic Cannabis
Description of Poisoning by Synthetic Cannabis
Synthetic cannabinoids are man-made molecules that interact with the endocannabinoid system in ways significantly more potent and potentially more dangerous that their distant plant-based cousins or the body's own versions of them. Overdoses are relatively common and can lead to severe adverse effects and deaths. Sold under the a great variety of street names such as "Spice," "Bonsai" or "K2" their chemical building blocks are often readily available for purchase on the internet. A recent meta-analyses from Australia (2019) describes AB-CHMINACA as being the most commonly seen synthetic cannabinoid in the accidental deaths of cases reported on the continent down under.
Synthetic Cannabis Issues
Injury, Poisoning and Certain Other Consequences of External Causes
ICD-10 Code: T40.4
Poisoning by Synthetic Cannabis Symptoms:
Confusion, paranoia, panic attacks, hallucinations, aphasia, ataxia, nausea/vomiting, seizure activity, organ failure, coma, death
Also known as:
Synthetic Cannabis Use Disorder
THC Interaction with Pharmaceutical Drugs
- THC can enhance the effects of drugs that cause sedation and depress the central nervous system, such as benzodiazepines, barbiturates, and alcohol, for example.
- THC is metabolized by and an inhibitor of a number of enzymatic liver pathways referred to as cytochrome P450. There are more than 50 enzymes belonging to this enzyme family, a number of which are responsible for the breakdown of common drugs such as antidepressants (e.g. amitriptyline, doxepine, fluvoxamine), antipsychotics (haloperidol, clozapine, stelazine), beta-blockers (e.g. propranolol), bronchodilators (e.g. theophylline), or bloodthinners (e.g. warfarin). Thus patients taking these classes of medication may find that THC increases the concentration and effects of these drugs as well as the duration of their effects.
- Clinical observation suggests no likely interactions with other pharmaceuticals at a total daily dose of up to 20mg THC.
CBD Interaction with Pharmaceutical Drugs
- CBD may alter action on metabolic enzymes (certain drug-transport mechanisms), and as such may alter interactions with other drugs, some of which may produce therapeutic or adverse effects. For instance, CBD interacts with the enzyme cytochrome P450 3A4 and cytochrome P450 2C19, increasing the bioavailability of anti-epileptic drugs such as clobazam (a benzodiazepine). This makes it possible to achieve the same results at significantly lower dosages, reducing treatment costs and risks of adverse effects.
- Groups of drugs affected include: anti-epileptic drugs, psychiatric drugs, and drugs affecting metabolic enzymes, for example.
- Clinical observations suggest no likely interactions with other pharmaceuticals at a total daily dose of up to 100mg CBD
THC Dosage Considerations
- THC micro dose: 0.1 mg to 0.4 mg
- THC low dose: 0.5 mg to 5 mg
- THC medium dose: 6 mg to 20 mg
- THC high dose: 21 mg to 50+ mg
CBD Dosage Considerations
- CBD low dose: 0.4 mg to 19 mg
- CBD medium dose: 20 mg to 99 mg
- CBD high dose: 100 mg to 800+ mg (upper limits tested ~1,500mg)
Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.
Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.